calendar
17 catalysts · 4 phase 2 initiation · 3 phase 1 completion · 3 phase 2 completion · 2 phase 3 initiation · 1 phase 0 trial completion · 1 phase iv trial initiation
next 91 dayslessmore
MonWedFri
17 catalysts · 4 phase 2 initiation · 3 phase 1 completion · 3 phase 2 completion · 2 phase 3 initiation · 1 phase 0 trial completion · 1 phase iv trial initiation
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Cardiovascular. Indication: Thrombophlebitis
Therapy area: Ophthalmology. Indication: Asthenopia (Eye Strain), Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Therapy area: Ophthalmology. Indication: Blepharitis, Ptosis
Therapy area: Cardiovascular, Gastrointestinal. Indication: Endothelial Dysfunction, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)
Therapy area: Cardiovascular, Respiratory. Indication: Asthma, Bronchitis, Emphysema, Pulmonary Edema
Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Myocardial Infarction
Therapy area: Cardiovascular. Indication: Atrial Fibrillation, Congestive Heart Failure (Heart Failure)
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Cardiovascular, Dermatology. Indication: Melasma (Chlosma), Venous Thromboembolism
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Cardiovascular, Metabolic Disorders. Indication: Congestive Heart Failure (Heart Failure), Type 2 Diabetes
Therapy area: Cardiovascular. Indication: Pulmonary Arterial Hypertension